A Company Built on a Promise

Here for people today and tomorrow

Striving for excellence every day at Fresenius Kabi

All meaningful care comes down to people with the experience, expertise, and compassion to make a difference in the lives of those facing challenging situations. For us, care is a fundamental obligation, mission, and daily source of inspiration. It is the momentum that pushes us forward to help elevate the quality of life for both caregivers and those who need it most: critically and chronically ill patients. By providing essential medicines and technologies for infusion, transfusion, and clinical nutrition, we are helping advance the future of healthcare, making it even more accessible, reliable, and in tune with current and future needs.

Learn more about our portfolio
young girl sleeping in intensive care unit

What guides us

The Fresenius Principles

The Fresenius Principles form the basis of our company culture, with which we support #FutureFresenius strategy. The Fresenius Principles describe what we stand for and how we operate, collaborate, approach challenges and make decisions – as individual Fresenius employees and as a whole team.

We care for excellence

No compromise on quality. True north in mind.

We care for excellence

No compromise on quality. True north in mind.

We bring healthcare innovation to people

Learning with our customers and partners. Pushing therapies to the next level.

We live the power of One Team

Respectful collaboration. Empowering responsibility.

We act today for a better tomorrow

Over 100 years of heritage. Mindful of future needs and resources.

The face(s) of care

The Fresenius Group structure

Stronger together

We are proud to be part of the Fresenius Group with its more than 178,000 employees worldwide. Every day, we use all dedication, expertise, and passion to help advance healthcare opportunities and make a difference in people’s lives everywhere. Together, the Fresenius Group has a combined annual revenue of €22.5 billion with a positive financial forecast for the coming years.

Operating companies

Fresenius Kabi

Assisting critically and chronically ill patients with quality solutions for infusion, transfusion, and clinical nutrition.

2025 sales > €8.6 billion

Fresenius Helios

Making an impact as Europe’s leading private hospital operator with HELIOS and Quirónsalud hospitals.

2025 sales > 13.5 billion

Learn more about Fresenius Helios

Investment companies

Fresenius Medical Care

Helping people with chronic kidney failure live their best lives through comprehensive products and services.

Learn more about Fresenius Medical Care

Consistent, long-term growth

A strong foundation to build on

As a company, we have continued to experience organic growth in all our key market sectors. Our broad industrial base, comprehensive range of system-critical healthcare products and leading market positions in clinical nutrition, medical technologies, and I.V. generic drugs. A clear financial strategy, combined with a high-performing team and a new leadership with revised governance ensures a profitable and productive future.

You are now leaving Fresenius Kabi Australia’s website, and are being redirected to an external website. Fresenius Kabi Australia takes no responsibility for the information contained on any sites that you will be accessing. The information that you are about to access may not comply with the Australian regulatory environment.

ACCEPT